OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
Rhea-AI Summary
OptimizeRx (Nasdaq: OPRX) will host a conference call on Thursday, March 5, 2026 at 4:30 p.m. ET to discuss fourth quarter results for the period ended December 31, 2025. A press release with the financial results will be issued before the call.
Access details include toll-free and international numbers, a webcast link, Conference ID 10206362, and a Call Me™ option. A replay will be available for 12 months in the company’s investors section.
Positive
- None.
Negative
- None.
News Market Reaction – OPRX
On the day this news was published, OPRX declined 4.36%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
OPRX is up 7.51% while peers show mixed moves (e.g., NRC -12.79%, DH -5.53%, SY +2.42%), pointing to a stock-specific reaction rather than a sector-wide move.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Apr 23 | Q1 2025 call setup | Neutral | +2.6% | Scheduled Q1 2025 earnings call with management presentation and Q&A. |
| Feb 27 | FY 2024 call setup | Neutral | +0.6% | Announced Q4 and full-year 2024 results conference call timing. |
| Oct 31 | Q3 2024 call setup | Neutral | -4.7% | Set date for Q3 2024 results call with webcast and replay access. |
| Jul 25 | Q2 2024 call setup | Neutral | +4.0% | Announced Q2 2024 conference call and pre-call earnings release plan. |
| Apr 26 | Q1 2024 update/call | Neutral | +15.0% | Provided business update and set date for Q1 2024 earnings call. |
Prior earnings-call scheduling headlines with the same tag saw an average move of 3.48%, generally modest but often positive, with one notably strong gain.
Recent news shows OPRX steadily updating investors through recurring earnings conference calls and business updates, with tag-matched call announcements on Apr 26, 2024, Jul 25, 2024, Oct 31, 2024, Feb 27, 2025, and Apr 23, 2025. These events produced mixed but generally constructive single-day moves, including a 15% gain on the April 2024 update. Today’s fourth quarter and full-year 2025 call notice continues that established communication cadence.
Historical Comparison
In the past, OPRX’s conferences/earnings call notices moved the stock by an average of 3.48%. Today’s 7.51% gain is stronger but directionally consistent with that pattern.
The company has maintained a regular cadence of quarterly earnings calls from 2024 into 2025, and this Q4/FY 2025 schedule continues that established investor communication pattern.
Market Pulse Summary
This announcement schedules OptimizeRx’s fourth quarter and full-year 2025 earnings call for March 5, 2026, continuing its established pattern of regular conference updates. Historical call notices with the same tag have produced an average move of 3.48%, sometimes more pronounced when expectations were elevated. Investors may focus on how Q4 results track against previously raised 2025 guidance and the company’s ongoing revenue and margin progression.
AI-generated analysis. Not financial advice.
WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thursday, March 5, 2026, at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter period ended December 31, 2025. The financial results will be issued in a press release prior to the call.
OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:
| Date: | Thursday, March 5, 2026 |
| Time: | 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) |
| Toll Free: | 1-844-825-9789 |
| International: | 1-412-317-5180 |
| Conference ID: | 10206362 |
| Call me™ Link: | https://callme.viavid.com/?$Y2FsbG1lPXRydWUmcGFzc2NvZGU9JmluZm89Y29tcGFueSZyPXRydWUmYj0xNg== |
| Call me™ Passcode: | 6586380 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1750927&tp_key=099094fd29 |
Please call the conference telephone number or log on to the web access link five minutes prior to the start time.
A replay of the call will remain available for 12 months via the investors section of the OptimizeRx website at http://www.optimizerx.com/investors.
About OptimizeRx
OptimizeRx is a leading healthcare technology company that’s redefining how life sciences brands connect with patients and HCPs. Our platform combines innovative, AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood® audiences to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and direct to consumer (DTC) strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.
Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.
For more information, follow the Company on LinkedIn or X, or visit www.optimizerx.com.
OptimizeRx Contact
Andy D’Silva, Chief Business Officer
adsilva@optimizerx.com
Investor Relations Contact
Steven Halper
LifeSci Advisors, LLC
shalper@lifesciadvisors.com
FAQ
When will OptimizeRx (OPRX) discuss Q4 2025 results and how can investors join the March 5, 2026 call?
What is the Conference ID and passcode for the OptimizeRx (OPRX) March 5, 2026 earnings call?
Will OptimizeRx (OPRX) publish Q4 2025 financial results before the March 5, 2026 call?
Where can I find the OptimizeRx (OPRX) webcast and how long will the replay be available?
What time should attendees join the OptimizeRx (OPRX) March 5, 2026 call to avoid missing the start?
